Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction

• Status: Completed
• Trial end date: 2012-08-01

Summary

Patients with advanced gastric cancer are treated with a combination of RAD001 (everolimus) and Mitomycin C.

• Phase: Phase 1

Details

• Lead Sponsor: Krankenhaus Nordwest
• Treatments: Everolimus; Mitomycin; Mitomycins; Sirolimus